Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung CancerG Krajnik, A Mohn-Staudner, J Thaler, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trialR Stelmach, S Lorenzen, T J Ettrich, et al.
ESMO Open|January 5, 2021
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrenceT Magnes, S Wagner, A R Thorner, et al.
Annals of Hematology|December 24, 1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor TherapyM A Fridrik, R Greil, H Hausmaninger, et al.
Leukemia|June 30, 2012
Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemiaO Merkel, N Wacht, E Sifft, et al.
Breast (Edinburgh, Scotland)|May 28, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancerC F Singer, M Filipits, S W Jahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2010
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categoriesM Fiegl, M Erdel, I Tinhofer, et al.
British Journal of Cancer|July 23, 2013
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trialM Gnant, G Pfeiler, H Stöger, et al.
British Journal of Cancer|September 27, 2007
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancerW Schippinger, H Samonigg, R Schaberl-Moser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2008
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclinesP Schmid, D Kühnhardt, P Kiewe, et al.
Pageof 12